• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Smith & Nephew’s Q2 earnings slide 56%

Smith & Nephew’s Q2 earnings slide 56%

August 1, 2013 By Brad Perriello

Smith & Nephew's Q2 earnings slide 56%

Smith & Nephew (FTSE:SN, NYSE:SNN) reported a 56% slide in 2nd-qaurter earnings on a 4% increase in sales.

The British medical device and wound care company posted profits of $129 million, or 14.2¢ per share, on sales of $1.07 billion for the 3 months ended June 29.

Adjusted to exclude 1-time items, earnings per share were 90¢, in-line with analysts’ expectations on Wall Street.

"The on-going implementation of our strategic priorities underpinned our performance in the quarter. We generated stand-out contributions from our areas of focused investment in the emerging and international markets and negative-pressure wound therapy. As expected orthopaedic reconstruction had a slow quarter and we anticipate a better 2nd half. Our major acquisition, Healthpoint Biotherapeutics, completed an excellent first 6 months as a Smith & Nephew business," CEO Olivier Bohuon said in prepared remarks. "Through the share buy-back programme and interim dividend we are delivering enhanced returns to our shareholders today. At the same time we continue to invest in the business, both for organic growth and enhancing our platform through agreed acquisitions in India, Brazil and now in Turkey. We are confident that our actions are reshaping the group for further success."

Smith & Nephew confirmed its outlook for the rest of the year, saying it expects its advanced wound management segment to "strongly out-perform," its trauma business to grow slightly, sports medicine to be in-line and orthopaedic reconstruction to be "below," according to a regulatory filing.

"We anticipate that the performance of orthopaedic reconstruction will improve in the 2nd half of the year," according to the filing.

SNN shares were trading at $56.93 apiece as of about 12:15 p.m. today, up 0.3%.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2013, Q2, Smith & Nephew

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy